Equities

Nyxoah SA

Nyxoah SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)8.64
  • Today's Change-0.12 / -1.37%
  • Shares traded16.62k
  • 1 Year change+70.08%
  • Beta0.5144
Data delayed at least 15 minutes, as of Nov 11 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

  • Revenue in EUR (TTM)5.08m
  • Net income in EUR-52.98m
  • Incorporated2009
  • Employees147.00
  • Location
    Nyxoah SARue Edouard Belin 12MONT-SAINT-GUIBERT 1435BelgiumBEL
  • Phone+32 26121755
  • Fax+32 10459075
  • Websitehttps://www.nyxoah.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Stille AB42.03m4.39m165.83m151.0033.822.8625.633.946.336.3360.9474.850.69782.108.494,598,368.007.287.038.708.1949.1743.9310.439.851.127.410.0021.9819.7016.78-2.485.3423.62--
Prim SA227.46m11.43m165.94m901.0014.501.317.430.72950.67170.671713.377.461.141.964.39252,736.005.736.688.348.9038.2838.115.026.431.13--0.13159.389.7710.0051.02-2.1412.86-5.01
Detection Technology Oyj-100.00bn-100.00bn205.18m464.00--2.78----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
Medistim ASA46.40m8.62m210.75m152.0024.426.1319.624.545.555.5529.8722.121.130.74617.483,599,204.0021.0522.9325.5328.5279.1278.2518.5820.642.75--0.018175.257.0010.06-8.9112.720.03314.87
Onward Medical NV0.00-35.15m228.50m99.00--8.42-----1.09-1.090.000.60790.00----0.00-66.40-55.70-79.20-61.60-------79,513.95----0.4855---34.62---10.40--32.59--
BICO Group AB194.24m-67.85m228.98m828.00--0.9199--1.18-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
Tristel Plc50.56m7.82m248.61m213.0032.056.3422.424.920.1350.1350.87140.68180.98121.815.74--15.189.3217.7510.7680.0880.7515.4711.093.04--0.1532109.3516.459.8945.469.9910.1319.53
Nyxoah SA5.08m-52.98m301.00m147.00--2.88--59.23-1.72-1.720.1663.040.03660.55692.3034,618.53-38.20-23.73-42.88-25.9861.7562.42-1,042.52-1,469.594.95-45.270.1822--40.99---38.39--100.58--
COLTENE Holding AG254.45m13.15m350.19m1.19k26.683.2917.111.382.062.0639.8916.731.271.386.06198,668.906.5510.4811.7018.7464.9062.685.177.470.861910.180.342179.94-9.133.54-54.05-6.81-7.72-7.79
Synektik SA143.07m18.38m357.02m164.0019.439.0117.412.509.329.3272.5420.092.0316.347.224,043,567.0026.0410.2441.6515.7926.6522.8612.858.851.2813.970.090947.00167.81--409.18------
IVF Hartmann Holding AG162.91m18.79m368.24m298.0019.592.4514.762.267.357.3563.7258.840.87883.148.52502,947.4010.147.2912.068.9055.2153.2911.548.303.95--0.005852.16-1.792.0934.951.49-14.8326.82
Guerbet SA826.24m32.76m377.34m2.92k11.900.96854.220.45672.512.5166.4230.820.81280.54935.56282,958.603.031.404.961.8678.5876.023.731.821.163.850.507357.824.30-0.0993158.05-12.615.23-10.07
Stratec SE250.54m10.01m387.84m1.46k38.731.7013.251.550.82360.823620.6118.740.56051.275.32164,609.702.247.072.858.2027.0427.324.009.700.92693.860.401140.81-4.636.88-55.293.30-2.16-7.68
Ion Beam Applications SA465.75m7.85m407.60m1.84k50.074.3520.790.87510.26890.268915.993.090.77212.152.70234,517.101.301.556.014.3234.1935.231.692.380.63723.770.399264.8318.6710.74-250.40---8.06--
medmix AG511.13m-1.92m426.91m2.70k--0.85936.960.8352-0.05-0.0511.3511.300.47783.405.58180,474.00-0.09962.06-0.12272.4932.5836.38-0.20854.161.062.210.436167.701.991.40-97.41-64.3612.01--
Data as of Nov 11 2024. Currency figures normalised to Nyxoah SA's reporting currency: Euro EUR

Institutional shareholders

13.29%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Sep 20241.39m4.05%
BlackRock Advisors LLCas of 03 Oct 20241.10m3.19%
BNP Paribas Asset Management Belgium SAas of 30 Aug 2024792.37k2.31%
Putnam Investment Management LLCas of 30 Sep 2024292.57k0.85%
Schroder Investment Management Ltd.as of 30 Jun 2024255.68k0.74%
Heights Capital Management, Inc.as of 30 Jun 2024183.59k0.53%
Swedbank Robur Fonder ABas of 30 Sep 2024175.00k0.51%
BNP Paribas Asset Management Europe SASas of 29 Nov 2023133.31k0.39%
AXA Investment Managers (Paris) SAas of 31 Oct 2023131.00k0.38%
Apo Asset Management GmbHas of 30 Sep 2023117.95k0.34%
More ▼
Data from 30 Apr 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.